mTOR Regulation of Metabolism in Hematologic Malignancies
Neoplastic cells rewire their metabolism, acquiring a selective advantage over normal cells and a protection from therapeutic agents. The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase involved in a variety of cellular activities, including the control of metabolic processes. mTOR...
Những tác giả chính: | Simone Mirabilii, Maria Rosaria Ricciardi, Agostino Tafuri |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2020-02-01
|
Loạt: | Cells |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/2073-4409/9/2/404 |
Những quyển sách tương tự
-
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
Bằng: Dániel Sztankovics, et al.
Được phát hành: (2024-03-01) -
IMPAIRED REGULATORY MECHANISMS OF THE mTOR SIGNALING PATHWAY IN OSTEOARTHROSIS
Bằng: Elena Vasilyevna Chetina, et al.
Được phát hành: (2012-12-01) -
Role of PPAR Receptor and Ligands in the Pathogenesis and Therapy of Hematologic Malignancies
Bằng: Jian Wu, et al.
Được phát hành: (2022-06-01) -
Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies
Bằng: Luca Lo Nigro
Được phát hành: (2023-12-01) -
Telocinobufagin suppresses malignant metastasis of undifferentiated thyroid carcinoma via modulation of the LARP1‐mTOR pathway
Bằng: Li‐Zhi Qiang, et al.
Được phát hành: (2025-03-01)